111 related articles for article (PubMed ID: 11562745)
1. TGF-beta1 promotes liver metastasis of pancreatic cancer by modulating the capacity of cellular invasion.
Teraoka H; Sawada T; Yamashita Y; Nakata B; Ohira M; Ishikawa T; Nishino H; Hirakawa K
Int J Oncol; 2001 Oct; 19(4):709-15. PubMed ID: 11562745
[TBL] [Abstract][Full Text] [Related]
2. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
Uchima Y; Sawada T; Nishihara T; Maeda K; Ohira M; Hirakawa K
Pancreas; 2004 Aug; 29(2):123-31. PubMed ID: 15257104
[TBL] [Abstract][Full Text] [Related]
3. Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer.
Teraoka H; Sawada T; Nishihara T; Yashiro M; Ohira M; Ishikawa T; Nishino H; Hirakawa K
Br J Cancer; 2001 Aug; 85(4):612-7. PubMed ID: 11506504
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis.
Inoue M; Sawada T; Uchima Y; Kimura K; Nishihara T; Tanaka H; Yashiro M; Yamada N; Ohira M; Hirakawa K
Oncol Rep; 2005 Dec; 14(6):1445-51. PubMed ID: 16273237
[TBL] [Abstract][Full Text] [Related]
5. Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis.
Rowland-Goldsmith MA; Maruyama H; Matsuda K; Idezawa T; Ralli M; Ralli S; Korc M
Mol Cancer Ther; 2002 Jan; 1(3):161-7. PubMed ID: 12467210
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 down-regulates ICAM-1 expression and enhances liver metastasis of pancreatic cancer.
Sawada T; Kimura K; Nishihara T; Onoda N; Teraoka H; Yamashita Y; Yamada N; Yashiro M; Ohira M; Hirakawa K
Adv Med Sci; 2006; 51():60-5. PubMed ID: 17357279
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system.
Ellenrieder V; Hendler SF; Ruhland C; Boeck W; Adler G; Gress TM
Int J Cancer; 2001 Jul; 93(2):204-11. PubMed ID: 11410867
[TBL] [Abstract][Full Text] [Related]
8. Action of antiproteases on pancreatic cancer cells.
Uchima Y; Sawada T; Hirakawa K
JOP; 2007 Jul; 8(4 Suppl):479-87. PubMed ID: 17625304
[TBL] [Abstract][Full Text] [Related]
9. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer.
Zong L; Chen K; Jiang Z; Chen X; Sun L; Ma J; Zhou C; Xu Q; Duan W; Han L; Lei J; Li X; Ma Q; Wang Z
J Exp Clin Cancer Res; 2017 Dec; 36(1):181. PubMed ID: 29228980
[TBL] [Abstract][Full Text] [Related]
10. Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs.
Zhang H; Morisaki T; Matsunaga H; Sato N; Uchiyama A; Hashizume K; Nagumo F; Tadano J; Katano M
Clin Exp Metastasis; 2000; 18(4):343-52. PubMed ID: 11448066
[TBL] [Abstract][Full Text] [Related]
11. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma.
Löhr M; Schmidt C; Ringel J; Kluth M; Müller P; Nizze H; Jesnowski R
Cancer Res; 2001 Jan; 61(2):550-5. PubMed ID: 11212248
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of metastatic and invasive capacity of gastric cancer cells by transforming growth factor-beta1.
Wang KS; Hu ZL; Li JH; Xiao DS; Wen JF
Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):179-86. PubMed ID: 16518542
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M
Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434
[TBL] [Abstract][Full Text] [Related]
15. Involvement of TNF-alpha in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress.
Wu W; Yamaura T; Murakami K; Ogasawara M; Hayashi K; Murata J; Saiki I
Oncol Res; 1999; 11(10):461-9. PubMed ID: 10850887
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells promote pancreatic adenocarcinoma cells invasion by transforming growth factor-β1 induced epithelial-mesenchymal transition.
Zhou HS; Su XF; Fu XL; Wu GZ; Luo KL; Fang Z; Yu F; Liu H; Hu HJ; Chen LS; Cai B; Tian ZQ
Oncotarget; 2016 Jul; 7(27):41294-41305. PubMed ID: 27191496
[TBL] [Abstract][Full Text] [Related]
17. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production.
Fan Y; Gan Y; Shen Y; Cai X; Song Y; Zhao F; Yao M; Gu J; Tu H
Oncotarget; 2015 Jun; 6(18):16120-34. PubMed ID: 25948792
[TBL] [Abstract][Full Text] [Related]
18. The effect of thrombospondin-1 and TGF-beta 1 on pancreatic cancer cell invasion.
Albo D; Berger DH; Tuszynski GP
J Surg Res; 1998 Apr; 76(1):86-90. PubMed ID: 9695745
[TBL] [Abstract][Full Text] [Related]
19. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
[TBL] [Abstract][Full Text] [Related]
20. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
